Baird Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
189,845
-6,000
| -3% | -$10.3K | ﹤0.01% | 1553 |
|
|
2025
Q1 | $652K | Hold |
195,845
| – | – | ﹤0.01% | 1310 |
|
|
2024
Q4 | $1.45M | Buy |
195,845
+2,000
| +1% | +$14.8K | ﹤0.01% | 1069 |
|
|
2024
Q3 | $1.82M | Buy |
193,845
+57,245
| +42% | +$538K | ﹤0.01% | 988 |
|
|
2024
Q2 | $1.1M | Buy |
136,600
+125,800
| +1,165% | +$1.01M | ﹤0.01% | 1138 |
|
|
2024
Q1 | $160K | Hold |
10,800
| – | – | ﹤0.01% | 1696 |
|
|
2023
Q4 | $87.8K | Buy |
+10,800
| New | +$87.8K | ﹤0.01% | 1683 |
|
|
2022
Q4 | – | Sell |
-19,055
| Closed | -$183K | – | 1726 |
|
|
2022
Q3 | $183K | Sell |
19,055
-179
| -0.9% | -$1.72K | ﹤0.01% | 1623 |
|
|
2022
Q2 | $212K | Sell |
19,234
-8,311
| -30% | -$91.6K | ﹤0.01% | 1681 |
|
|
2022
Q1 | $459K | Buy |
27,545
+995
| +4% | +$16.6K | ﹤0.01% | 1446 |
|
|
2021
Q4 | $507K | Sell |
26,550
-4,517
| -15% | -$86.3K | ﹤0.01% | 1463 |
|
|
2021
Q3 | $766K | Buy |
+31,067
| New | +$766K | ﹤0.01% | 1310 |
|
|
2021
Q2 | – | Sell |
-7,325
| Closed | -$232K | – | 1757 |
|
|
2021
Q1 | $232K | Sell |
7,325
-34,561
| -83% | -$1.09M | ﹤0.01% | 1596 |
|
|
2020
Q4 | $1.94M | Buy |
41,886
+8,625
| +26% | +$400K | 0.01% | 815 |
|
|
2020
Q3 | $1.1M | Buy |
33,261
+4,233
| +15% | +$139K | ﹤0.01% | 918 |
|
|
2020
Q2 | $797K | Buy |
29,028
+17,983
| +163% | +$494K | ﹤0.01% | 1000 |
|
|
2020
Q1 | $331K | Buy |
+11,045
| New | +$331K | ﹤0.01% | 1182 |
|